Abstract
In the past 20 years, photosensitisers have found a niche in the photodynamic treatment of accessible tumours (PDT). Most of the therapeutics involved in this approach are porphyrin-based natural products or derivatives. However, there is a range of other photodynamic agents derived from natural sources – either via direct extraction/purification, or via semisynthesis - currently being trialled both for anticancer PDT and the related antimicrobial application, covering areas such as wound disinfection and blood product sterilisation. The following review covers the advances made in the potential photoantimicrobial application of natural product photosensitisers and their derivatives.
Keywords: Antimicrobial, photosensitiser, singlet oxygen, porphyrin, perylenequinonoid, anthraquinone, isoquinoline, furocoumarin
Current Bioactive Compounds
Title: Natural Product Photoantimicrobials
Volume: 3 Issue: 4
Author(s): M. Wainwright
Affiliation:
Keywords: Antimicrobial, photosensitiser, singlet oxygen, porphyrin, perylenequinonoid, anthraquinone, isoquinoline, furocoumarin
Abstract: In the past 20 years, photosensitisers have found a niche in the photodynamic treatment of accessible tumours (PDT). Most of the therapeutics involved in this approach are porphyrin-based natural products or derivatives. However, there is a range of other photodynamic agents derived from natural sources – either via direct extraction/purification, or via semisynthesis - currently being trialled both for anticancer PDT and the related antimicrobial application, covering areas such as wound disinfection and blood product sterilisation. The following review covers the advances made in the potential photoantimicrobial application of natural product photosensitisers and their derivatives.
Export Options
About this article
Cite this article as:
Wainwright M., Natural Product Photoantimicrobials, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220202
DOI https://dx.doi.org/10.2174/157340707783220202 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry In Silico Analysis of Amino Acid Sequences in Relation to Specificity and Physiochemical Properties of Mesophilic and Thermophilic Antileukemic L-Asparaginases
Current Biotechnology Development of Arene Ruthenium Antitumor Complexes
Mini-Reviews in Medicinal Chemistry Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and LDopa Treatment
Current Genomics Synthesis and Comparison of the Antitumor Activities of Steroids on ABCB1-transfected Mouse Lymphoma and Human Ovary Carcinoma
Letters in Drug Design & Discovery Autophagy in Chronic Myeloid Leukaemia: Stem Cell Survival and Implication in Therapy
Current Cancer Drug Targets Genetically Engineered Stem Cells for Therapeutic Gene Delivery
Current Gene Therapy RAS/RAF/MEK Inhibitors in Oncology
Current Medicinal Chemistry Functional Consequences of Immune Cell Adhesion to Endothelial Cells
Current Pharmaceutical Design Platinum-Intercalator Conjugates: From DNA-Targeted Cisplatin Derivatives to Adenine Binding Complexes as Potential Modulators of Gene Regulation
Current Topics in Medicinal Chemistry The Effects of Caffeine on the Cholinergic System
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)]
Current Cancer Drug Targets Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Containing a Substituted Piperazine
Letters in Drug Design & Discovery Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets Recent Progress in the Development of Synthetic Hybrids of Natural or Unnatural Bioactive Compounds for Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates
Current Topics in Medicinal Chemistry Genetic Variation at the Human MGMT Locus and its Biological Consequences
Current Pharmacogenomics Current Developments in the Therapeutic Potential of S-Nitrosoglutathione, an Endogenous NO-Donor Molecule
Current Pharmaceutical Biotechnology